USD
+$0.00
(+0.00%
)At Close (As of Sep 17, 2025)
$428.86M
Market Cap
-
P/E Ratio
-0.95
EPS
$17.82
52 Week High
$5.71
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $182M |
Total Revenue | $266M |
Cost Of Revenue | $84M |
Costof Goods And Services Sold | $84M |
Operating Income | -$34M |
Selling General And Administrative | $198M |
Research And Development | $9.2M |
Operating Expenses | $207M |
Investment Income Net | - |
Net Interest Income | -$15M |
Interest Income | $3.3M |
Interest Expense | $19M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $6M |
Income Before Tax | -$50M |
Income Tax Expense | $664K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$50M |
Comprehensive Income Net Of Tax | - |
Ebit | -$31M |
Ebitda | -$25M |
Net Income | -$50M |
Field | Value (USD) |
---|---|
Total Assets | $233M |
Total Current Assets | $151M |
Cash And Cash Equivalents At Carrying Value | $87M |
Cash And Short Term Investments | $87M |
Inventory | $12M |
Current Net Receivables | $48M |
Total Non Current Assets | $81M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $49M |
Intangible Assets Excluding Goodwill | $49M |
Goodwill | $21M |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $4.6M |
Other Non Current Assets | - |
Total Liabilities | $227M |
Total Current Liabilities | $63M |
Current Accounts Payable | $9.2M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $1.7M |
Total Non Current Liabilities | $164M |
Capital Lease Obligations | $8.5M |
Long Term Debt | $122M |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $130M |
Other Current Liabilities | $52M |
Other Non Current Liabilities | - |
Total Shareholder Equity | $5.5M |
Treasury Stock | - |
Retained Earnings | -$609M |
Common Stock | $1K |
Common Stock Shares Outstanding | $62M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$18M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $6M |
Capital Expenditures | $1.5M |
Change In Receivables | - |
Change In Inventory | $3.3M |
Profit Loss | - |
Cashflow From Investment | -$4.8M |
Cashflow From Financing | $47M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$50M |
Field | Value (USD) |
---|---|
Gross Profit | $182M |
Total Revenue | $266M |
Cost Of Revenue | $84M |
Costof Goods And Services Sold | $84M |
Operating Income | -$34M |
Selling General And Administrative | $198M |
Research And Development | $9.2M |
Operating Expenses | $207M |
Investment Income Net | - |
Net Interest Income | -$15M |
Interest Income | $3.3M |
Interest Expense | $19M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $6M |
Income Before Tax | -$50M |
Income Tax Expense | $664K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$50M |
Comprehensive Income Net Of Tax | - |
Ebit | -$31M |
Ebitda | -$25M |
Net Income | -$50M |
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC
Evolus, Inc., a high-performance beauty company, provides aesthetic medical products for physicians and their patients in the United States. The company is headquartered in Newport Beach, California.